PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE

Issues of pathogenesis of the calcified aortic stenosis and ischemic heart disease in the elderly are considered. The relevance of early detection of angina, syncope, and dyspnea in view of their non-specific and subclinical course for early detection of heart disease is specified. Current scientifi...

Full description

Bibliographic Details
Main Authors: N. Yu. Karpova, M. A. Rashid, N. A. Shostak, I. V. Pogonchenkova, T. V. Kazakova
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/174
_version_ 1797232446638391296
author N. Yu. Karpova
M. A. Rashid
N. A. Shostak
I. V. Pogonchenkova
T. V. Kazakova
author_facet N. Yu. Karpova
M. A. Rashid
N. A. Shostak
I. V. Pogonchenkova
T. V. Kazakova
author_sort N. Yu. Karpova
collection DOAJ
description Issues of pathogenesis of the calcified aortic stenosis and ischemic heart disease in the elderly are considered. The relevance of early detection of angina, syncope, and dyspnea in view of their non-specific and subclinical course for early detection of heart disease is specified. Current scientific views on the myocardial bioenergy and its role in the genesis of chronic heart failure are presented. Particular attention is paid to the place of cytoprotectors, especially trimetazidine, in the management of patients with cardiac N.Yu. Karpova1diseases.
first_indexed 2024-03-08T14:05:51Z
format Article
id doaj.art-532099e749a84298bc17e75af0b3b1f6
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-04-24T16:00:24Z
publishDate 2015-09-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-532099e749a84298bc17e75af0b3b1f62024-04-01T07:43:22ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-0111443143710.20996/1819-6446-2015-11-4-431-437174PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASEN. Yu. Karpova0M. A. Rashid1N. A. Shostak2I. V. Pogonchenkova3T. V. Kazakova4Pirogov Russian National Research Medical UniversityMoscow City Hospital №56Pirogov Russian National Research Medical UniversityMoscow City Hospital №56Pirogov Russian National Research Medical UniversityIssues of pathogenesis of the calcified aortic stenosis and ischemic heart disease in the elderly are considered. The relevance of early detection of angina, syncope, and dyspnea in view of their non-specific and subclinical course for early detection of heart disease is specified. Current scientific views on the myocardial bioenergy and its role in the genesis of chronic heart failure are presented. Particular attention is paid to the place of cytoprotectors, especially trimetazidine, in the management of patients with cardiac N.Yu. Karpova1diseases.https://www.rpcardio.online/jour/article/view/174calcified aortic stenosisischemic heart diseasecytoprotectorstrimetazidineheart bioenergy
spellingShingle N. Yu. Karpova
M. A. Rashid
N. A. Shostak
I. V. Pogonchenkova
T. V. Kazakova
PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
Рациональная фармакотерапия в кардиологии
calcified aortic stenosis
ischemic heart disease
cytoprotectors
trimetazidine
heart bioenergy
title PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
title_full PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
title_fullStr PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
title_full_unstemmed PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
title_short PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
title_sort prospects for cytoprotectors use in the elderly patients through the example of calcified aortic stenosis and ischemic heart disease
topic calcified aortic stenosis
ischemic heart disease
cytoprotectors
trimetazidine
heart bioenergy
url https://www.rpcardio.online/jour/article/view/174
work_keys_str_mv AT nyukarpova prospectsforcytoprotectorsuseintheelderlypatientsthroughtheexampleofcalcifiedaorticstenosisandischemicheartdisease
AT marashid prospectsforcytoprotectorsuseintheelderlypatientsthroughtheexampleofcalcifiedaorticstenosisandischemicheartdisease
AT nashostak prospectsforcytoprotectorsuseintheelderlypatientsthroughtheexampleofcalcifiedaorticstenosisandischemicheartdisease
AT ivpogonchenkova prospectsforcytoprotectorsuseintheelderlypatientsthroughtheexampleofcalcifiedaorticstenosisandischemicheartdisease
AT tvkazakova prospectsforcytoprotectorsuseintheelderlypatientsthroughtheexampleofcalcifiedaorticstenosisandischemicheartdisease